- UltraTech Cement’s net income was 17 billion rupees, which is a 0.6% increase year-over-year but below the estimated 17.87 billion rupees.
- Revenue reached 180.7 billion rupees, marking a 1.9% rise from the previous year, short of the estimated 182.61 billion rupees.
- Total costs were 161.3 billion rupees, reflecting a 3.1% increase year-over-year.
- Profit before depreciation, interest, tax, and other income stood at 32.05 billion rupees.
- UltraTech Cement shares fell by 2.4%, closing at 11,370 rupees with 261,812 shares traded.
- Analyst recommendations include 34 buys, 4 holds, and 4 sells.
- Comparisons are based on the company’s original disclosures.
A look at Ultratech Cement Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Ultra Tech Cement Ltd., a leading producer of cement products, is poised for a stable long-term outlook based on the Smartkarma Smart Scores analysis. With a balanced score of 3 in Value, Dividend, and Growth categories, the company demonstrates a solid foundation for sustained performance. Additionally, scoring 4 in Resilience and Momentum, Ultratech Cement showcases its ability to withstand market fluctuations and maintain positive growth momentum.
As part of Larsen & Toubro’s cement operations, Ultratech Cement benefits from a diversified product range and strong industry presence. Owned primarily by Grasim Industries, this company’s Smart Scores reflect a robust overall outlook, positioning it well for potential long-term growth and stability in the cement industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
